Does hyperandrogenic statute in the polycystic ovary syndrome constitute an obstacle to the success of in vitro fertilization?

被引:5
|
作者
Gaddas, M. [1 ]
Chaouache, N. [1 ]
Ajina, M. [2 ]
Tabka, Z. [1 ]
Ajina, M. Zaouali [1 ]
机构
[1] Fac Med Ibn el Jazzar, Lab Physiol & Explorat Fonct, Ave Mohamed Karoui, Sousse 4000, Tunisia
[2] CHU Farhat Hached, Unite Med Reprod, Ave Ibn el Jazzar, Sousse 4000, Tunisia
来源
JOURNAL DE GYNECOLOGIE OBSTETRIQUE ET BIOLOGIE DE LA REPRODUCTION | 2016年 / 45卷 / 09期
关键词
Hyperandrogenism; IVF; Polycystic ovarian; syndrome; SYNDROME PCOS; ANDROGEN RECEPTORS; INSULIN-RESISTANCE; DOWN-REGULATION; WOMEN; TESTOSTERONE; CYCLES; CELL; STIMULATION; APOPTOSIS;
D O I
10.1016/j.jgyn.2016.08.007
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objectives. The aim of this study was to evaluate the impact of initial androgenic statute of women with polycystic ovary syndrome (SOPK) on the expected results of in vitro fertilization (FIV). Materials and methods. It is about an exploratory study carried out in 61 unfertile SOPK patients, having profited all from a cycle of FIV/ICSI (intracytoplasmic sperm injection). We have divided our population in two groups according to their hormonal androgenic statute: groups with hyperandrogenism and without hyperandrogenism. We proceeded to note the anthropometric and hormonal parameters as well as results of FIV for each of the two groups. Results. SOPK patients with hyperandrogenism are more obese than their counterparts. Also, they have more oocytes collected after ovarian induction. In addition, we did not reveal any significant differences between our two study groups concerning parameters defining FIV response. Conclusion. Our findings suggest that hyperandrogenism statute in SOPK infertile women does not seem to compromise the results of FIV. On the contrary, it would make it possible to optimize the chances to puncture more significant number of oocytes. (C) 2016 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:1091 / 1098
页数:8
相关论文
共 50 条
  • [31] Influencing factors and effects of low oocyte retrieval in patients with polycystic ovary syndrome undergoing in-vitro fertilization
    Yin, Huiqun
    Zhu, Jie
    Wang, Cunli
    Luan, Kang
    Wu, Yan
    Ni, Feng
    EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2025, 304 : 97 - 103
  • [32] Infertile polycystic ovary syndrome patients undergoing in vitro fertilization with the gonadotropin-releasing hormone-antagonist protocol: role of hyperandrogenism
    Yang, Wan
    Yang, Rui
    Yang, Shuo
    Li, Jia
    Tu, Binbin
    Gao, Chang
    Wang, Ying
    GYNECOLOGICAL ENDOCRINOLOGY, 2018, 34 (08) : 715 - 718
  • [33] Does hyperandrogenism have an effect on hearing loss in patients with polycystic ovary syndrome?
    Oghan, Fatih
    Coksuer, Hakan
    AURIS NASUS LARYNX, 2012, 39 (04) : 365 - 368
  • [34] Pelvic floor muscle strength and urinary incontinence in hyperandrogenic women with polycystic ovary syndrome
    Antonio, Flavia Ignacio
    Bo, Kari
    Ferriani, Rui Alberto
    Silva de Sa, Marcos Felipe
    Japur de Sa Rosa e Silva, Ana Carolina
    Jorge Ferreira, Cristine Homsi
    INTERNATIONAL UROGYNECOLOGY JOURNAL, 2013, 24 (10) : 1709 - 1714
  • [35] Age at Menarche and Its Potential Role in Early Detection of Hyperandrogenic Polycystic Ovary Syndrome
    Manthey, C.
    Lynn, C. D.
    Ocobock, C.
    Cepon-Robins, T. J.
    Warrener, A.
    AMERICAN JOURNAL OF BIOLOGICAL ANTHROPOLOGY, 2025, 186 (04):
  • [36] Metformin reduces risk of ovarian hyperstimulation syndrome in patients with polycystic ovary syndrome during gonadotropin-stimulated in vitro fertilization cycles: a randomized, controlled trial
    Palomba, Stefano
    Falbo, Angela
    Carrillo, Laura
    Villani, Maria Teresa
    Orio, Francesco
    Russo, Tiziana
    Di Cello, Annalisa
    Cappiello, Fulvio
    Capasso, Sabina
    Tolino, Achille
    Colao, Annamaria
    Mastrantonio, Pasquale
    La Sala, Giovanni Battista
    Zullo, Fulvio
    Cittadini, Ettore
    FERTILITY AND STERILITY, 2011, 96 (06) : 1384 - U369
  • [37] In vitro maturation and fertilization of oocytes from unstimulated ovaries in infertile women with polycystic ovary syndrome
    Zhao, Jun-Zhao
    Zhou, Wei
    Zhang, Wei
    Ge, Hong-Shan
    Huang, Xue-Feng
    Lin, Jin-Ju
    FERTILITY AND STERILITY, 2009, 91 (06) : 2568 - 2571
  • [38] The role of FTO variants in the susceptibility of polycystic ovary syndrome and in vitro fertilization outcomes in Chinese women
    Liu, Ai Ling
    Liao, Hong Qing
    Zhou, Jing
    Nie, Yu Lin
    Zhou, Cui Lan
    Li, Zhi Liang
    Guo, Zi Fen
    He, Dong Xiu
    Zhu, Yun Hua
    Peng, Cui Ying
    GYNECOLOGICAL ENDOCRINOLOGY, 2018, 34 (08) : 719 - 723
  • [39] Outcomes of in vitro fertilization cycles among patients with polycystic ovary syndrome following ovarian puncture for in vitro maturation
    Lin, Jia
    Wang, Peiyu
    Zhao, Junzhao
    Xiao, Shiquan
    Yu, Rong
    Jin, Congcong
    Zhu, Ruru
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2016, 135 (03) : 319 - 323
  • [40] The association between polycystic ovary syndrome and ectopic pregnancy after in vitro fertilization and embryo transfer
    Wang, Jing
    Wei, Yongyue
    Diao, Feiyang
    Cui, Yugui
    Mao, Yundong
    Wang, Wei
    Liu, Jiayin
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2013, 209 (02) : 139.e1 - 139.e9